This Treatment Can Improve Your Odds Of Surviving C. Diff Infection

By Dennis Thompson HealthDay ReporterTHURSDAY, April 9, 2026 (HealthDay News) — Prompt treatment with a fecal transplant can ...
MedPage Today on MSN

Multiple Drugs Flagged for Higher C. Diff Risk

Increased risks observed for analgesics and corticosteroids, among others, in Swedish stud ...
Acsh.org

We Can Do Better Tackling C. diff

C. diff is a horrible disease that can cause significant morbidity. It can and often does recur and kills around 30,000 Americans every year. We have made progress in prevention and treatment, but ...
Becker's Hospital Review

Routinely prescribed antibiotic may not be best severe C. diff treatment

Current guidelines recommend using either metronidazole or vancomycin to treat C. diff infections. “For many years the two antibiotics were considered to be equivalent in their ability to cure C. diff ...
Seeking Alpha

Acurx Undervalued And Set For Potential M&A With Next-Gen C. Diff Treatment

There are inherent risks in biotech investing. A decade’s worth and often hundreds of millions of dollars in R&D, along with binary risks of failed clinical trials or regulatory approval. Above and ...
Becker's Hospital Review

Low-Dose Antibiotics as Effective as High-Dose in C. diff Treatment

Researchers at the American Society for Microbiology’s 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy have reported that low-dose antibiotic treatments appear to be as effective ...
Becker's ASC

The therapies that could shape the future of C diff treatment

Fecal microbiota transplantation has become one of the most effective treatments for recurrent Clostridioides difficile infections, but its long-term role in gastroenterology may hinge on moving ...
News Medical

UTHealth scientist receives $1.9 million from NIH to develop non-antibiotic treatment for C. diff infections

Charles Darkoh, Ph.D., a researcher at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, was recently awarded a five-year, $1.9 million R01 grant by the ...
Becker's ASC

Series Therapeutics initiating new phase-II study for C. Diff treatment: 6 insights

After reporting non-statistically significant results in it a phase-II study, Cambridge, Mass.-based Seres Therapeutics is launching a revised phase-II study for its SER-109 Clostridium Difficile ...
Seeking Alpha

Acurx stock plunges 26% amid Phase 2 data release for C. diff drug

Acurx Pharmaceuticals (NASDAQ:ACXP) stock plunged 26% in midday trading amid the release of data from a Phase 2b clinical trial for its C. diff treatment ibezapolstat. The biotech company said the ...
The American Journal of Managed Care

Christian John Lillis Lists Benefits of Microbiome-Based Therapeutics for C difficile Treatment

Christian John Lillis, cofounder and executive director of the Peggy Lillis Foundation for C difficile Education & Advocacy, explained how FDA-approved microbiome-based therapeutics help to treat and ...
Verywell Health on MSN

What to eat when you have C diff (Clostridioides difficile)

Medically reviewed by Lindsey Waldman, MD, RD Key Takeaways Eat foods with probiotics like yogurt and kefir to help replenish ...